Director Robert N. Duelks filed a Form 4 with the SEC on November 12, 2026, reporting the grant of 645 Deferred Stock Units and 2,659 stock options in Broadridge Financial Solutions, Inc. (NYSE:BR) on November 10, 2026.

Key Highlights

  • DSU Grant: Duelks received 645 Deferred Stock Units on November 10, 2026, at a price of $0.0000, under Broadridge's 2018 Omnibus Award Plan.
  • Stock Option Grant: 2,659 stock options (right to buy) were granted on November 10, 2026, with an exercise price of $192.96 and an expiration date of November 10, 2036.
  • Immediate Vesting: According to the filing, both the Deferred Stock Units and the stock options vest immediately upon grant.
  • DSU Settlement: The filing states the Deferred Stock Units "will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge."
  • Direct Holdings Following Transaction: Duelks directly beneficially owned 21,876 shares of common stock following the reported transaction.
  • Indirect Holdings: Duelks also holds shares indirectly: 4,474 shares through BOMAR II LLC, 17,000 shares through Mary E. Duelks 2020 Irrevocable Trust, and 8,600 shares through Robert N. Duelks 2007 Revocable Trust.

Director Grant Details for Robert N. Duelks at Broadridge Financial Solutions

According to the Form 4 filed on November 12, 2026, Robert N. Duelks, a director of Broadridge Financial Solutions, Inc. (NYSE:BR), reported two equity grants dated November 10, 2026. The first was an acquisition of 645 Deferred Stock Units at a price of $0.0000. The filing explains that this grant was made under Broadridge's 2018 Omnibus Award Plan and that the units "vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge."

The second grant consisted of 2,659 stock options with the right to buy common stock at an exercise price of $192.96 per share. The filing indicates these options became exercisable on November 10, 2026, the same date as the grant, and expire on November 10, 2036. Following both transactions, Duelks directly held 2,659 derivative securities in the form of stock options.

In addition to the 21,876 shares directly owned after the transactions, the filing reports indirect beneficial ownership of common stock in three separate arrangements: 4,474 shares held through BOMAR II LLC, 17,000 shares held through the Mary E. Duelks 2020 Irrevocable Trust, and 8,600 shares held through the Robert N. Duelks 2007 Revocable Trust. The Form 4 was signed by Maria Allen as Power of Attorney on November 12, 2026.

What Was Disclosed

The filing disclosed two equity grants to director Robert N. Duelks in Broadridge Financial Solutions on November 10, 2026: 645 Deferred Stock Units at $0.0000 under the 2018 Omnibus Award Plan, and 2,659 stock options at an exercise price of $192.96, both vesting immediately upon grant.